Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-08-09
2011-08-09
Vivlemore, Tracy (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S04400A
Reexamination Certificate
active
07994306
ABSTRACT:
A method of treating a CD24-related medical condition is disclosed. The method comprises administering to a subject in need thereof at least one siRNA molecule selected from the group consisting of SEQ ID NO: 1 to 4. Pharmaceutical compositions comprising same are also disclosed.
REFERENCES:
patent: 2003/0106084 (2003-06-01), Liu et al.
patent: 2004/0097448 (2004-05-01), Watt
patent: 2005/0245475 (2005-11-01), Khvorova et al.
patent: WO 03/079982 (2003-10-01), None
patent: WO 2008/059491 (2008-05-01), None
Communication Pursuant to Article 94(3) EPC Dated Jan. 27, 2010 From the European Patent Office Re.: Application No. 07827369.5.
International Preliminary Report on Patentability Dated May 28, 2009 From the International Bureau of WIPO Re.: Application No. PCT/IL2007/001396.
International Search Report and the Written Opinion Dated Feb. 27, 2008 From the International Searching Authority Re.: Application No. PCT/IL2007/001396.
Sagiv et al. “CD24 Is A Novel Oncogene in Corectal Cancer, Detected by Microarray Profiling of Cell Transformation, and Is A Target for Immunotherapy of Cancer”, Gastroenterology, 130(4, Supp1.2): A680: W1549, 2006. Digestive Disease Week Meeting/107th Annual Meeting of the American-Gastroenterological-Association, Los Angeles, CA, USA, May 2006.
Smith et al. “The Metastasis-Associated Gene CD24 Is Regulated by Ral GTPase and Is A Mediator of Cell Proliferation and Survival in Human Cancer”, Cancer Research, 66(4): 1917-1922, 2006. p. 1922, 1-h Col.
Response Dated May 23, 2010 to Communication Pursuant to Article 94(3) EPC of Jan. 27, 2010 From the European Patent Office Re.: Application No. 07827369.5.
Arber Nadir
Sagiv Eyal
The Medical Research, Infrastructure and Health Services Fund of
Vivlemore Tracy
LandOfFree
Methods of treating cancer using siRNA molecules directed... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating cancer using siRNA molecules directed..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating cancer using siRNA molecules directed... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626491